Carisma Therapeutics Inc.

NASDAQ: CARM · Real-Time Price · USD
0.45
-0.05 (-10.41%)
At close: Jun 20, 2025, 3:59 PM

Carisma Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-0.29 -1.13 -0.02 -3.64
PEG Ratio
0.01 0.01 -0.00 0.55
PS Ratio
0.88 6.58 0.13 5.60
PB Ratio
-0.62 3.70 -0.03 12.78
P/FCF Ratio
-0.29 -1.19 -0.11 -3.79
P/OCF Ratio
-0.29 -1.21 -0.17 -3.98
OCF/S Ratio
-3.05 -5.44 -0.77 -1.41
Debt / Equity Ratio
-0.09 0.12 -0.82 0.23
Quick Ratio
1.48 5.06 2.82 7.06
Current Ratio
1.48 5.06 2.78 3.87
Asset Turnover
0.64 0.17 0.14 0.75
Interest Coverage
n/a n/a -17.86 n/a
Return on Equity
2.17 -3.27 1.24 -3.51
Return on Assets
-1.99 -0.97 -0.85 -1.15
Return on Invested Capital
-3.48 -1.17 -0.92 -1.42
Dividend Yield
n/a 0.12 n/a n/a
Payout Ratio
n/a -0.14 n/a n/a
Gross Profit Margin
1.00 -3.97 0.38 1.00
Net Profit Margin
-3.08 -5.82 -6.23 -1.54
Pretax Profit Margin
-3.08 -5.82 -6.23 -1.54
Operating Profit Margin
-3.17 -5.95 -5.71 -1.54
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-2.91 -5.76 -5.29 -1.51